Search
for

    Sort by

    Research 61–90 of 66

    1. Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities 2009 · 11 citations
    2. Antiandrogens as Therapies for COVID-19: A Systematic Review Cancers · 2024 · 6 citations
    3. Cancer-Related Alopecia: From Etiologies to Global Management Cancers · 2021 · 4 citations
    4. Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity Current Issues in Molecular Biology · 2025
    5. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature Clinical and Experimental Dermatology · 2023
    6. Triple Hormonal Blockade (ADT3): A Patient’s Perspective Oncogen · 2019
    7. Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide Journal of Medicinal Chemistry · 2008 · 88 citations
    8. Clinical applications of antiandrogens Journal of Steroid Biochemistry · 1988 · 29 citations
    9. Hormone Blocking Anticancer Drugs 2015
    10. ANTIANDROGEN THERAPY IN DERMATOLOGY International Journal of Dermatology · 1996 · 32 citations
    11. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013 · 48 citations
    12. Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production Bioorganic & Medicinal Chemistry Letters · 2007 · 17 citations
    13. (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production Bioorganic & Medicinal Chemistry Letters · 2007 · 14 citations
    14. Pantolactams as androgen receptor antagonists for the topical suppression of sebum production Bioorganic & Medicinal Chemistry Letters · 2011 · 5 citations
    15. Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase Asian journal of Current Research in Clinical Cancer · 2022
    16. Incidence of alopecia from endocrine therapies in cancer Journal of The American Academy of Dermatology · 2013
    17. Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment Journal of The American Academy of Dermatology · 2013
    18. Onychomatricoma with classic features: Case report and review of the literature Journal of The American Academy of Dermatology · 2013
    19. Is dehydroepiandrosterone a hormone? Journal of Endocrinology · 2005 · 403 citations
    20. Androgenic Effects on Ventricular Repolarization Circulation · 2019 · 64 citations
    21. Are sex discordant outcomes in COVID-19 related to sex hormones? Seminars in Oncology · 2020 · 42 citations
    22. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    23. Understanding and Addressing Hair Disorders in Transgender Individuals American Journal of Clinical Dermatology · 2018 · 32 citations
    24. Androgen receptor modulators: a review of recent patents and reports (2012-2018) Expert Opinion on Therapeutic Patents · 2019 · 23 citations
    25. <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring Endocrinology · 2005 · 20 citations
    26. Chapter 17. Selective androgen receptor modulators (SARMs) Annual Reports in Medicinal Chemistry · 2001 · 18 citations
    27. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study Archives of Cardiovascular Diseases · 2019 · 17 citations
    28. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations
    29. Therapeutic Androgen Receptor Ligands Nuclear Receptor Signaling · 2003 · 16 citations
    30. Targets to treat androgen excess in polycystic ovary syndrome Expert Opinion on Therapeutic Targets · 2015 · 14 citations